APA-Zitierstil (7. Ausg.)

Hänse, N., Marmé, F., & Haag, G. M. (2016). A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors. BMC cancer, 16, . https://doi.org/10.1186/s12885-016-2449-0

Chicago-Zitierstil (17. Ausg.)

Hänse, Nicole, Frederik Marmé, und Georg Martin Haag. "A Phase I Trial of the Trifunctional Anti Her2 × Anti CD3 Antibody Ertumaxomab in Patients with Advanced Solid Tumors." BMC Cancer 16 (2016). https://doi.org/10.1186/s12885-016-2449-0.

MLA-Zitierstil (9. Ausg.)

Hänse, Nicole, et al. "A Phase I Trial of the Trifunctional Anti Her2 × Anti CD3 Antibody Ertumaxomab in Patients with Advanced Solid Tumors." BMC Cancer, vol. 16, 2016, https://doi.org/10.1186/s12885-016-2449-0.